What happened Shares of Tenet Healthcare (NYSE: THC) were tumbling 10.3% lower as of 3:21 p.m. EDT on Friday. The decline came after SunTrust analyst David MacDonald lowered his one-year price target for the stock to $18 per share from $42 per share. So what Long-term investors shouldn't be concerned about Wall Street price target fluctuations. Analysts by nature focus on the near-term prospects for companies they cover. Image source: Getty Images. Having said that, Tenet does face some stiff headwinds in the short run that are likely to negatively impact the hospital chain's profits. The COVID-19 pandemic is straining hospitals' capacities in many areas of the U.S. Tenet and most of its peers are pushing back elective surgeries, which tend to be more profitable, as they brace for the worst with the novel coronavirus outbreak. However, Tenet might not have to worry too much about covering the costs of uninsured patients with COVID-19 who are treated in its hospitals. The Trump administration appears likely to use part of the federal stimulus bill to compensate hospitals that treat uninsured patients with COVID-19 and then absorb the cost. Now what Healthcare stocks, especially shares of major hospital chains, will almost certainly continue to be volatile over the next few months. The next two quarterly updates from Tenet will reveal just how much impact the pandemic has made on the company financially. However, the long-term prospects for Tenet shouldn't be affected much by the current crisis. 10 stocks we like better than Tenet HealthcareWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Tenet Healthcare wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of March 18, 2020 Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.Source